Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
43
QIPT Quote, Financials, Valuation and Earnings
Last price:
$3.53
Seasonality move
:
-7.1%
Day range:
$3.53 - $3.54
52-week range:
$1.35 - $3.54
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.62x
P/B ratio:
1.55x
Volume:
373K
Avg. volume:
821.9K
1-year change:
26.07%
Market cap:
$155.4M
Revenue:
$245.4M
EPS (TTM):
-$0.25
Analysts' Opinion
-
Consensus RatingQuipt Home Medical Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 1 Hold rating, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $3.83, Quipt Home Medical Corp. has an estimated upside of 8.36% from its current price of $3.53.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $3.65 representing 100% downside risk from its current price of $3.53.
Fair Value
-
According to the consensus of 3 analysts, Quipt Home Medical Corp. has 8.36% upside to fair value with a price target of $3.83 per share.
QIPT vs. S&P 500
-
Over the past 5 trading days, Quipt Home Medical Corp. has overperformed the S&P 500 by 0.52% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Quipt Home Medical Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Quipt Home Medical Corp. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Quipt Home Medical Corp. reported revenues of $68.3M.
Earnings Growth
-
Quipt Home Medical Corp. earnings have been falling on a year-over-year basis for 11 quarters in a row. In the most recent quarter Quipt Home Medical Corp. reported earnings per share of -$0.08.
Enterprise value:
273M
EV / Invested capital:
--
Price / LTM sales:
0.62x
EV / EBIT:
12.19x
EV / Revenue:
1.11x
PEG ratio (5yr expected):
-0.27x
EV / Free cash flow:
10.55x
Price / Operating cash flow:
5.91x
Enterprise value / EBITDA:
6.27x
Gross Profit (TTM):
$131.7M
Return On Assets:
-4.14%
Net Income Margin (TTM):
-4.31%
Return On Equity:
-9.95%
Return On Invested Capital:
-5.08%
Operating Margin:
-0.91%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $214.2M | $254.6M | $245.4M | $61.3M | $68.3M | |
| Gross Profit | $119.2M | $137.4M | $131.7M | $32.1M | $36M | |
| Operating Income | $5M | $3.4M | -$1.9M | -$426K | -$621K | |
| EBITDA | $42.1M | $51.7M | $43.5M | $11.1M | $11.3M | |
| Diluted EPS | -$0.07 | -$0.16 | -$0.25 | -$0.07 | -$0.08 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $57.2M | $41.5M | $65.4M | $73.1M | $78.3M | |
| Total Assets | $108.6M | $132.2M | $247.4M | $247.2M | $305.8M | |
| Current Liabilities | $32.7M | $41.7M | $60.6M | $60.9M | $74.7M | |
| Total Liabilities | $50M | $52.7M | $136.3M | $140.1M | $193.7M | |
| Total Equity | $58.6M | $79.5M | $111.1M | $107.2M | $112.1M | |
| Total Debt | $27M | $32.3M | $99.4M | $99.8M | $111.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $37.2M | $35.7M | $38.5M | $7.2M | $10M | |
| Cash From Investing | -$83.3M | -$10.6M | -$33.5M | -$3.7M | -$23.7M | |
| Cash From Financing | $54.8M | -$26.2M | -$8M | -$1.9M | $15.4M | |
| Free Cash Flow | $30.3M | $25.1M | $25.9M | $3.4M | $8.1M | |
QIPT
Sector
Market Cap
$155.4M
$27.6M
Price % of 52-Week High
99.72%
50.06%
Dividend Yield
0%
0%
Shareholder Yield
-3.43%
-1.55%
1-Year Price Total Return
26.07%
-18.12%
Beta (5-Year)
0.507
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$3.53
200-day SMA
Buy
Level
$2.31
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$3.06
Relative Strength Index (RSI14)
Buy
Level
84.07
ADX Line
Neutral
Level
0
Williams %R
Sell
Level
-0.9524
50-day SMA
Buy
Level
$2.66
MACD (12, 26)
Buy
Level
0.98
25-day Aroon Oscillator
Buy
Level
56
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.317)
Sell
CA Score
(Annual)
Level (-0.7206)
Buy
Beneish M-Score
(Annual)
Level (-2.9945)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (1.5656)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Quipt Home Medical Corp. engages in the provision of in-home monitoring and disease management services including end-to-end respiratory solutions. Its services include sleep apnea and pap treatment, home ventilation, equipment solutions, daily and ambulatory aides, power mobility, respiratory equipment rental, and oxygen therapy. The company was founded on March 5, 1997 and is headquartered in Wilder, KY.
Stock Forecast FAQ
In the current month, QIPT has received 1 Buy ratings 1 Hold ratings, and 1 Sell ratings. The QIPT average analyst price target in the past 3 months is $3.83.
-
Where Will Quipt Home Medical Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Quipt Home Medical Corp. share price will rise to $3.83 per share over the next 12 months.
-
What Do Analysts Say About Quipt Home Medical Corp.?
Analysts are divided on their view about Quipt Home Medical Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Quipt Home Medical Corp. is a Sell and believe this share price will drop from its current level to $3.65.
-
What Is Quipt Home Medical Corp.'s Price Target?
The price target for Quipt Home Medical Corp. over the next 1-year time period is forecast to be $3.83 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 1 rates the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is QIPT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Quipt Home Medical Corp. is a Hold. 1 of 3 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of QIPT?
You can purchase shares of Quipt Home Medical Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Quipt Home Medical Corp. shares.
-
What Is The Quipt Home Medical Corp. Share Price Today?
Quipt Home Medical Corp. was last trading at $3.53 per share. This represents the most recent stock quote for Quipt Home Medical Corp.. Yesterday, Quipt Home Medical Corp. closed at $3.53 per share.
-
How To Buy Quipt Home Medical Corp. Stock Online?
In order to purchase Quipt Home Medical Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get QIPT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
QIPT
Sector
P/E ratio
--
23.89x
PEG ratio
-0.27x
-0.01x
P/B ratio
1.55x
1.81x
Price / LTM sales
0.62x
1.58x
Growth Metrics
QIPT
Sector
Revenue growth
11.38%
4.6%
Earnings growth
-9.66%
10.88%
Revenue (5-year growth)
27.56%
6.46%
Earnings forecast
$0.02
-$0.18
Profitability
QIPT
Sector
Profitability FY 2025
$131.7M
$3.6M
Return on invested capital
-5.08%
-31.84%
Return on assets
-4.14%
-27.96%
Return on equity
-9.95%
-37.63%
Earnings Date
Last Earnings Date
Aug
11
Next Earnings Date
Feb
9
Estimated Next Earnings Date
Nov
10
Balance Sheet
QIPT
Sector
Total cash
$12.9M
$26.3M
Short term investments
--
$25.7M
Total assets
$305.8M
$78M
Long term debt
$111.9M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
FTAI alert for Dec 31
FTAI Aviation Ltd. [FTAI] is down 0.38% over the past day.
Sell
45
LYEL alert for Dec 31
Lyell Immunopharma, Inc. [LYEL] is down 2.63% over the past day.
Sell
30
CORT alert for Jan 1
Corcept Therapeutics, Inc. [CORT] is down 50.44% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
